BvcaEuropean Private Equity

The London markets and private equity-backed IPOs', prepared for the BVCA and the London Stock Exchange by Oxera, examines certain aspects relevant to assessing the attractiveness of the London markets for private equity-backed IPOs. The report specifically looks at the proportion of private equity-backed companies that float on the London markets, their after-market

Contact Details: 3clements Inn London London WC2A 2AZ United Kingdom Tel: 020-7025 2950 Fax: 020-7025 2951 Email: bvca@bvca.co.uk WWW: www.bvca.co.uk

Loading...

BioNews Results for BvcaEuropean Private Equity:
Timminco Completes $5.3 Million Private Placement Equity Financing	Genetic Engineering News:  Nov 20 2009 10:48PM Matching: private equity
Asthma drug developer raises $17 million	Reuters:  Nov 18 2009 3:18PM Matching: private equity
Australian Patent Lawyers Claim Patenting Genes Is Necessary For Biomedical Research	AltAssets.net:  Nov 18 2009 10:51AM Matching: private equity
The future of private equity	Genetic Engineering News:  Nov 16 2009 5:55PM Matching: private equity
PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain	Pharma Live:  Nov 14 2009 1:00AM Matching: private equity
Promote your company here: BioNewsCast - Press Release Distribution	→View more BvcaEuropean Private Equity news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 167 times since April 2007, the link to the organisation's website has been followed 41 times

Search for more companies in London

Search for more companies in London

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for BvcaEuropean Private Equity